Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Curr Probl Cardiol ; 48(8): 101735, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37044270

RESUMEN

The effectiveness of polypill therapy in the prevention and treatment of cardiovascular disorders is still unclear. This meta-analysis aimed to assess the efficacy of polypill therapy in reducing cardiovascular risk factors. We conducted a systematic search of PubMed, Cochrane CENTRAL, SCOPUS, and Google Scholar for randomized controlled trials (RCTs) that evaluated polypill therapy for cardiovascular diseases, hypertension, or dyslipidemia. We included 18 RCTs with a total of 20,463 participants in our analysis. Pooled effect estimates were reported as Odds ratios (ORs) with a 95% confidence interval (CI) using a random-effects model. Polypill therapy was associated with a statistically significant reduction in systolic blood pressure (SBP) (OR: -0.33, 95% CI [-0.64, -0.03]; P-value = 0.03), diastolic blood pressure (DBP) (OR: -0.70, 95% CI [-1.20, -0.21]; P-value = 0.005), and total cholesterol level (OR: -1.25, 95% CI [-1.82, -0.68]; P-value < 0.0001). Polypill therapy also showed improved adherence (OR 2.18, 95% CI [1.47, 3.24]; P-value = 0.0001). However, there was no statistically significant benefit in the reduction of all-cause mortality, major cardiovascular events, and LDL-c levels. The use of polypill therapy is associated with a statistically significant reduction in SBP, DBP, and total cholesterol levels, as well as improved adherence. Further research is needed to determine its impact on hard clinical outcomes such as mortality and major cardiovascular events.


Asunto(s)
Enfermedades Cardiovasculares , Hipertensión , Humanos , Presión Sanguínea , Enfermedades Cardiovasculares/prevención & control , Colesterol/uso terapéutico , Hipertensión/tratamiento farmacológico , Ensayos Clínicos Controlados Aleatorios como Asunto
2.
Phys Chem Chem Phys ; 11(44): 10385-90, 2009 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-19890523

RESUMEN

The first definitive infrared signatures of the elusive NCCO radical have been measured using a microwave discharge technique combined with low-temperature matrix-isolation spectroscopy, resulting in a consistent set of vibrational assignments for six isotopologues. The infrared spectra of these NCCO isotopologues were concomitantly established by rigorous variational nuclear-motion computations based on a high-level coupled-cluster quartic vibrational force field [ROCCSD(T)/cc-pCVQZ] and cubic dipole field [ROCCSD/cc-pCVTZ]. Our experimental and theoretical results for NCCO overturn the vibrational assignments in a NIST-JANAF compilation and those from a recent two-dimensional cross-spectral correlation analysis. For the parent isotopologue at 11 K in a nitrogen matrix, we find the signature bands nu(2)(CO str.) = 1889.2 cm(-1) and nu(3)(CC str.) = 782.0 cm(-1). Our variational vibrational computations reveal strong mixing of the nu(3) stretching fundamental and the nu(4) + nu(5) bending combination level for all isotopologues. These Fermi resonances manifest a clear breakdown of the simple normal-mode picture of molecular vibrations at low energies.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...